{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T19:05:50Z","timestamp":1767899150469,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30597-y","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T23:17:30Z","timestamp":1764371850000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigating the impact of oxygen concentration on the assembly of human papillomavirus virus like particles"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuying","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenshuang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ercui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongcai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"issue":"1","key":"30597_CR1","first-page":"1","volume":"7","author":"M Wei","year":"2018","unstructured":"Wei, M. et al. N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro. Emerg. Microbes Infections. 7 (1), 1\u201312 (2018).","journal-title":"Emerg. Microbes Infections"},{"key":"30597_CR2","unstructured":"Knipe, D. M. et al. Fields Virology (Lippincott Williams & Wilkins, 2013)."},{"issue":"8","key":"30597_CR3","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1128\/JVI.77.8.4818-4826.2003","volume":"77","author":"RL Finnen","year":"2003","unstructured":"Finnen, R. L., Erickson, K. D., Chen, X. S. & Garcea, R. L. Interactions between papillomavirus L1 and L2 capsid proteins. J. Virol. 77 (8), 4818\u20134826 (2003).","journal-title":"J. Virol."},{"key":"30597_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13027-018-0185-6","volume":"13","author":"JD Combes","year":"2018","unstructured":"Combes, J. D. & Franceschi, S. Human papillomavirus genome variants and head and neck cancers: a perspective. Infect. Agents Cancer. 13, 1\u20137 (2018).","journal-title":"Infect. Agents Cancer"},{"key":"30597_CR5","doi-asserted-by":"crossref","unstructured":"Li, Z. et al. Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity. Nat. Commun. 9 (1). (2018).","DOI":"10.1038\/s41467-018-07199-6"},{"issue":"4","key":"30597_CR6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nrc.2018.13","volume":"18","author":"R Roden","year":"2018","unstructured":"Roden, R. & Stern, P. L. Opportunities and challenges for human papillomavirus vaccination in cancer. Nat. Rev. Cancer. 18 (4), 240\u2013254 (2018).","journal-title":"Nat. Rev. Cancer"},{"issue":"35","key":"30597_CR7","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1016\/j.vaccine.2017.06.084","volume":"35","author":"Y Gu","year":"2017","unstructured":"Gu, Y. et al. Characterization of an Escherichia coli-derived human papillomavirus type 16 and 18 bivalent vaccine. Vaccine 35 (35), 4637\u20134645 (2017).","journal-title":"Vaccine"},{"key":"30597_CR8","doi-asserted-by":"publisher","unstructured":"Li, Z. et al. Crystal structures of two immune complexes identify determinants for viral infectivity and type-specific neutralization of human papillomavirus. MBio 8 (5). https:\/\/doi.org\/10.1128\/mbio (2017). 00787\u2009\u2013\u200917.","DOI":"10.1128\/mbio"},{"key":"30597_CR9","doi-asserted-by":"crossref","unstructured":"Zhao, Q. et al. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Virol. J. 9 (1). (2012).","DOI":"10.1186\/1743-422X-9-52"},{"issue":"3","key":"30597_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1097-2765(00)80449-9","volume":"5","author":"XS Chen","year":"2000","unstructured":"Chen, X. S., Garcea, R. L., Goldberg, I., Casini, G. & Harrison, S. C. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell. 5 (3), 557\u2013567 (2000).","journal-title":"Mol. Cell"},{"issue":"10","key":"30597_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Rold\u00e3o","year":"2010","unstructured":"Rold\u00e3o, A., Mellado, M. C. M., Castilho, L. R., Carrondo, M. J. & Alves, P. M. Virus-like particles in vaccine development. Expert Rev. Vaccines. 9 (10), 1149\u20131176 (2010).","journal-title":"Expert Rev. Vaccines"},{"issue":"7\u20138","key":"30597_CR12","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1080\/21645515.2019.1625644","volume":"15","author":"TF Schwarz","year":"2019","unstructured":"Schwarz, T. F. et al. A ten-year study of immunogenicity and safety of the AS04-HPV-16\/18 vaccine in adolescent girls aged 10\u201314 years. Hum. Vaccines Immunotherapeutics. 15 (7\u20138), 1970\u20131979 (2019).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"issue":"19","key":"30597_CR13","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland, S. M. et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med. 356 (19), 1928\u20131943 (2007).","journal-title":"N. Engl. J. Med."},{"issue":"9580","key":"30597_CR14","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","volume":"369","author":"J Paavonen","year":"2007","unstructured":"Paavonen, J. et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 (9580), 2161\u20132170 (2007).","journal-title":"Lancet"},{"issue":"9","key":"30597_CR15","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/INF.0000000000000773","volume":"34","author":"T Vesikari","year":"2015","unstructured":"Vesikari, T. et al. A randomized, double-blind, phase III study of the immunogenicity and safety of a 9-valent human papillomavirus L1 virus-like particle vaccine (V503) versus Gardasil\u00ae in 9\u201315-year-old girls. Pediatr. Infect. Dis. J. 34 (9), 992\u2013998 (2015).","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"30597_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jnci\/djz074","volume":"112","author":"YL Qiao","year":"2020","unstructured":"Qiao, Y. L. et al. Efficacy, Safety, and immunogenicity of an Escherichia coli-Produced bivalent human papillomavirus vaccine: an interim analysis of a randomized clinical trial. J. Natl. Cancer Inst. 112 (2), 145\u2013153 (2020).","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"30597_CR17","doi-asserted-by":"publisher","first-page":"2329450","DOI":"10.1080\/21645515.2024.2329450","volume":"20","author":"C Zhao","year":"2024","unstructured":"Zhao, C. et al. Opportunities and challenges for human papillomavirus vaccination in China. Hum. Vaccines Immunotherap. 20 (1), 2329450 (2024).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"30597_CR18","first-page":"100780","volume":"37","author":"S Aggarwal","year":"2023","unstructured":"Aggarwal, S., Agarwal, P. & Singh, A. K. Human papilloma virus vaccines: A comprehensive narrative review. Cancer Treat. Res. Commun. 37, 100780 (2023).","journal-title":"Cancer Treat. Res. Commun."},{"key":"30597_CR19","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/j.vaccine.2006.05.119","volume":"24","author":"S Inglis","year":"2006","unstructured":"Inglis, S., Shaw, A. & Koenig, S. HPV vaccines: commercial research & development. Vaccine 24, S99\u2013S105 (2006).","journal-title":"Vaccine"},{"issue":"2","key":"30597_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1021\/bp0502781","volume":"22","author":"SJ Hanslip","year":"2006","unstructured":"Hanslip, S. J., Zaccai, N. R., Middelberg, A. P. & Falconer, R. J. Assembly of human papillomavirus type-16 virus\u2010like particles: multifactorial study of assembly and competing aggregation. Biotechnol. Prog. 22 (2), 554\u2013560 (2006).","journal-title":"Biotechnol. Prog."},{"issue":"9","key":"30597_CR21","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1099\/0022-1317-76-9-2407","volume":"76","author":"M Sapp","year":"1995","unstructured":"Sapp, M., Volpers, C., M\u00fcller, M. & Streeck, R. E. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. J. Gen. Virol. 76 (9), 2407\u20132412 (1995).","journal-title":"J. Gen. Virol."},{"issue":"3","key":"30597_CR22","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1128\/JVI.72.3.2160-2167.1998","volume":"72","author":"M Li","year":"1998","unstructured":"Li, M., Beard, P., Estes, P. A., Lyon, M. K. & Garcea, R. L. Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J. Virol. 72 (3), 2160\u20132167 (1998).","journal-title":"J. Virol."},{"issue":"5","key":"30597_CR23","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1128\/JVI.79.5.2839-2846.2005","volume":"79","author":"CB Buck","year":"2005","unstructured":"Buck, C. B., Thompson, C. D., Pang, Y. Y. S., Lowy, D. R. & Schiller, J. T. Maturation of papillomavirus capsids. J. Virol. 79 (5), 2839\u20132846 (2005).","journal-title":"J. Virol."},{"issue":"1","key":"30597_CR24","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0042-6822(02)00099-5","volume":"308","author":"Y Ishii","year":"2003","unstructured":"Ishii, Y., Tanaka, K. & Kanda, T. Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids. Virology 308 (1), 128\u2013136 (2003).","journal-title":"Virology"},{"issue":"2","key":"30597_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1586\/erv.12.151","volume":"12","author":"JW Wang","year":"2013","unstructured":"Wang, J. W. & Roden, R. B. Virus-like particles for the prevention of human papillomavirus-associated malignancies. Expert Rev. Vaccines. 12 (2), 129\u2013141 (2013).","journal-title":"Expert Rev. Vaccines"},{"key":"30597_CR26","doi-asserted-by":"publisher","first-page":"112836","DOI":"10.1016\/j.jim.2020.112836","volume":"486","author":"F Bursa","year":"2020","unstructured":"Bursa, F. et al. Estimation of ELISA results using a parallel curve analysis. J. Immunol. Methods. 486, 112836 (2020).","journal-title":"J. Immunol. Methods"},{"key":"30597_CR27","doi-asserted-by":"crossref","unstructured":"Aitken, A. & Learmonth, M. Estimation of disulfide bonds using ellman\u2019s reagent. The Protein Protocols Handbook 487\u2013488. (1996).","DOI":"10.1007\/978-1-60327-259-9_82"},{"key":"30597_CR28","doi-asserted-by":"crossref","unstructured":"Thannhauser, T. W., Konishi, Y. & Scheraga, H. A. Analysis for disulfide bonds in peptides and proteins. Methods in Enzymology, (Elsevier, 1987).","DOI":"10.1016\/0076-6879(87)43020-6"},{"key":"30597_CR29","doi-asserted-by":"crossref","unstructured":"Kirnbauer, R. et al. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. In: Proceedings of the National Academy of Sciences. (1992).","DOI":"10.1073\/pnas.89.24.12180"},{"issue":"1","key":"30597_CR30","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/s41467-020-16639-1","volume":"11","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles. Nat. Commun. 11 (1), 2841 (2020).","journal-title":"Nat. Commun."},{"issue":"3","key":"30597_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3390\/vaccines9030239","volume":"9","author":"CA Gonelli","year":"2025","unstructured":"Gonelli, C. A. et al. Immunogenicity of HIV-1-Based Virus-Like particles with increased incorporation and stability of Membrane-Bound Env. Vaccines 9 (3), 239 (2025).","journal-title":"Vaccines"},{"key":"30597_CR32","unstructured":"Wang, L. Z. Use of baculovirus expression system for generation of virus-like particles: successes and challenges. Protein Expression Purification (2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30597-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T14:32:12Z","timestamp":1767882732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30597-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30597"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30597-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1027"}}